Skip to main content
Fig. 4 | Stem Cell Research & Therapy

Fig. 4

From: LncRNA NORAD promotes bone marrow stem cell differentiation and proliferation by targeting miR-26a-5p in steroid-induced osteonecrosis of the femoral head

Fig. 4

miR-26a-5p was a target and was negatively regulated by NORAD. a StarBase online provided the putative binding sites of NORAD and miR-26a-5p. b Dual-luciferase reporter gene assay was performed to confirm the binding between NORAD and miR-26a-5p. c The miR-26a-5p expression in bone marrow samples from patients with SONFH (n = 20) and femoral neck fracture (control, n = 20) was detected by RT-qPCR. d The correlation between NORAD expression and miR-26a-5p expression in patients with SONFH was analyzed by Spearman’s correlation analysis. e The miR-26a-5p expression in hBMSCs was detected by RT-qPCR. **P < 0.01 compared with control group, ##P < 0.01 compared with Vector and si-NC group

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512